Susquehanna International Group
ZBIO

Susquehanna International Group’s ProShares UltraPro Short NASDAQ Biotechnology ZBIO Stock Holding History

Susquehanna International Group’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-20,322
Closed -$186K – 11280
2019
Q4 		$186K Buy
20,322
+7,791
+62% +$94.7K ﹤0.01% 8824
2019
Q3 		$211K Buy
12,531
+2,449
+24% +$36.5K ﹤0.01% 8998
2019
Q2 		$136K Buy
+10,082
New +$151K ﹤0.01% 9442
2018
Q4 		– Sell
-27,954
Closed -$360K – 10452
2018
Q3 		$360K Buy
27,954
+7,838
+39% +$113K ﹤0.01% 7120
2018
Q2 		$363K Buy
20,116
+10,173
+102% +$205K ﹤0.01% 7464
2018
Q1 		$208K Sell
9,943
-4,779
-32% -$93.6K ﹤0.01% 8268
2017
Q4 		$334K Buy
+14,722
New +$342K ﹤0.01% 7407
2017
Q3 		– Sell
-11,867
Closed -$319K – 10002
2017
Q2 		$319K Sell
11,867
-2,419
-17% -$78.3K ﹤0.01% 7480
2017
Q1 		$479K Buy
+14,286
New +$526K ﹤0.01% 6565
2016
Q4 		– Sell
-6,133
Closed -$289K – 10423
2016
Q3 		$259K Buy
6,133
+660
+12% +$30.5K ﹤0.01% 7173
2016
Q2 		$354K Sell
5,473
-7,561
-58% -$465K ﹤0.01% 6693
2016
Q1 		$944K Buy
+13,034
New +$966K ﹤0.01% 5207

Other funds holding ZBIO

Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Susquehanna International Group's ZBIO Position: Q1 2020 in Review

Susquehanna International Group sold out of ProShares UltraPro Short NASDAQ Biotechnology (ZBIO) in Q1 2020, closing a stake of 20,322 shares — an estimated $186K sold.

Susquehanna International Group first reported a position in ZBIO in Q1 2016 and held it in 12 quarters. The position peaked at $944K in Q1 2016. 1 fund tracked by Wall St. Rank holds ZBIO as of Q1 2020.

  • Susquehanna International Group reported no remaining ProShares UltraPro Short NASDAQ Biotechnology position as of Q1 2020 after selling out during the quarter.
  • Susquehanna International Group sold 20,322 ProShares UltraPro Short NASDAQ Biotechnology shares in Q1 2020, an estimated $186K.
  • Susquehanna International Group first reported a position in ProShares UltraPro Short NASDAQ Biotechnology in Q1 2016 and held it in 12 quarters.
  • Susquehanna International Group's ProShares UltraPro Short NASDAQ Biotechnology position peaked at $944K in Q1 2016.
  • 1 fund tracked by Wall St. Rank held ProShares UltraPro Short NASDAQ Biotechnology as of Q1 2020.

Based on Susquehanna International Group's 13F filing for Q1 2020, filed 15 May 2020.